Evaluation of an antiretroviral medication attitude scale and relationships between medication attitudes and medication nonadherence

AIDS Patient Care and STDs

Volumn 19, Issue 5, 2005, Pages 306-316

  Viswanathan, Hema ^a   Anderson, Rodney ^b   Thomas III, Joseph ^a  

^a PURDUE UNIVERSITY   (United States)

^b New Century Medical Imaging   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; CD4 ANTIGEN; PROTEINASE INHIBITOR; RNA DIRECTED DNA POLYMERASE INHIBITOR;

ADULT; AFRICAN AMERICAN; AGE; AGED; ARTICLE; CELL COUNT; CORRELATION ANALYSIS; DEMOGRAPHY; EDUCATION; ETHNOLOGY; EUROPEAN AMERICAN; FACTORIAL ANALYSIS; FEMALE; GENDER; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INCOME; MAJOR CLINICAL STUDY; MALE; MULTIPLE REGRESSION; PATIENT ATTITUDE; PATIENT COMPLIANCE; RATING SCALE; SAMPLING; SCORING SYSTEM; SOCIAL SUPPORT; UNITED STATES; WORK;

ADOLESCENT; ADULT; AGED; ANTI-HIV AGENTS; CROSS-SECTIONAL STUDIES; FEMALE; HIV INFECTIONS; HUMANS; INDIANA; MALE; MIDDLE AGED; PATIENT COMPLIANCE; SELF ADMINISTRATION; TREATMENT REFUSAL;

EID: 20044368287     PISSN: 10872914     EISSN: None     Source Type: Journal    
DOI: 10.1089/apc.2005.19.306     Document Type: Article

References (42)

1. Department of Health and Human Services Panel on Clinical Practices for Treatment of HIV infection. Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents. 2004. aidsinfo. nih.gov/guidelines/adult/ AA_102904.pdf. (Last accessed November 24, 2004).
2. Fisch M, Richman D, Grieco M, et al. The efficacy of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex. A double blind, placebo controlled trial. N Engl J Med 1987;317:185-191.
3. Gulick R, Mellors J, Havlir D, et al. Treatment with indinavir, zidovudine, and lamivudine in adults with human immunodeficiency virus infection and CD4 cell counts of 200 per cubic millimeter or less. N Engl J Med 1997;337:734-739.
4. Hammer S, Squires K, Hughes M, et al. A controlled trial of two nucleoside analogues plus indinavir in persons with human immunodeficiency virus infection and CD4 cell counts of 200 per cubic millimeter or less. N Engl J Med 1997;337:725-733.
5. Cameron DW, Health-Chiozzi M, Danner S, et al. Randomized placebo-controlled trial of ritonavir in advanced HIV disease. The Advanced HIV Disease Ritonavir Study Group. Lancet 1998;351:543-549.
6. Ostrop NJ, Hallett KA, Gill MJ. Long-term patient adherence to antiretroviral therapy. Ann Pharmacother 2000;34;703-709.
7. Haubrich RH, Little SJ, Currier JS, et al. The value of patient-reported adherence to antiretroviral therapy in predicting virologic and immunoloigic response. AIDS 1999;13:1099-1107.
8. Paterson DL, Swindells S, Mohr J, et al. Adherence to protease inhibitor therapy and outcomes in patients with HIV infection. Ann Intern Med 2000;113:21-30.
9. Miller LG, Hays RD. Adherence to combination antiretroviral therapy: Synthesis of the literature and clinical implications. AIDS Read 2000;10:177-185.
10. Ickovics JR, Cameron A, Zackin R, et al. Consequences and determinants of adherence to antiretroviral medication: results from Adult AIDS Clinical Trials Group protocol 370. Antivir Ther 2002;7: 185-193.
11. Gifford AL, Borrman JE, Shively MJ, et al. Predictors of self-reported adherence and plasma HIV concentrations in patients on multidrug antiretroviral regimens. J Acquir Immune Defic Syndr 2000;23:386-395.
12. Demasi RA, Graham NM, Toison JM, et al. Correlation between self-reported adherence to highly active antiretroviral therapy (HAART) and virologic outcome. Adv Ther 2001;18:163-173.
13. Singh N, Squier C, Sivek C, et al. Determinants of compliance with antiretroviral therapy in patients with human immunodeficiency virus: Prospective assessment with implications for enhancing compliance. AIDS Care 1996;8:261-269.
14. Ostrop NJ, Hallett KA, Gill MJ. Long-term patient adherence to antiretroviral therapy. Ann Pharmacother 2000;34:703-709.
15. Holzemer WL, Corless IB, Nokes KM, et al. Predictors of self-reported adherence in persons living with HIV disease. AIDS Patient Care STDS 1999;13:185-197.
16. Gordillo V, Del Amo J, Soriano V, Gonzalez-Lahoz J. Sociodemographic and psychological variables influencing adherence to antiretroviral therapy. AIDS 1999;13:1763-1769.
17. Singh N, Berman SM, Swindells S, et al. Adherence of human immunodeficiency virus-infected patients to antiretroviral therapy. Clin Infect Dis 1999;29:824-830.
18. Siegel K, Karus D, Schrimshaw EW. Racial differences in attitudes toward protease inhibitors among older HIV-infected men. AIDS Care 2000;12:423-434.
19. Becker MH, Maiman LA, Kirscht JO, et al. Patient perceptions and adherence: recent studies of the Health Belief Model. In: Hayes RB, et al., eds. Adherence in Health Care. Baltimore, MD: Johns Hopkins University Press; 1979:78-112.
20. Smith MY, Rapkin BD, Morrison A, Kammerman S. Zidovudine adherence in persons with AIDS. The relation of patient beliefs about medication to self-termination of therapy. J Gen Intern Med 1997;12: 216-223.
21. Williams A, Friedland G. Adherence, compliance, and HAART. AIDS Clin Care 1997;9:51-55.
22. Conrad P. The meaning of medications: another look at compliance. Soc Sci Med 1985;40:29-37.
23. Trostle JA, Hauser WA, Susser IS. The logic of non-compliance: Management of epilepsy from the patient's point of view. Culture Med Psychiatry 1983; 7:35-56.
24. Roberts KJ, Mann T. Barriers to antiretroviral medication adherence in HIV-infected women. AIDS Care 2000;12:377-386.
25. Dunbar-Jacob J, Erlen JA, Schlenk EA, et al. Adherence in chronic disease. Annu Rev Nurs Res 2000;18:48-90.
26. Gao X, Nau DP, Rosenbluth SA, et al. The relationship of disease severity, health beliefs and medication adherence among HIV patients. AIDS Care 2000; 12:387-398.
27. Morisky DE, Ward HJ, Liu KY. Self-reported medication taking behavior: A valid indicator for assessing compliance. Presentation at 129th American Public Health Association Meeting. Atlanta, GA: September 2001.
28. Morisky DE, Green LW, Levine DM. Concurrent and predictive validity of a self-reported measure of medication adherence. Med Care 1986;24:67-74.
29. Greenglass ER, Fiskenbaum L, Burke RJ. The relationship between social support and burnout over time in teachers. In: Crandall R, Perrewe PL, eds. Occupational Stress: A Handbook. Bristol, PA: Taylor and Francis, 1995, pp. 239-248.
30. Devellis RF, ed. Scale Development Theory and Applications. Thousand Oaks, CA: Sage Publications Inc, 1991.
31. Nunnally JC, ed. Psychometric Theory. New York: McGraw Hill, 1978.
32. Ferguson TF, Stewart KE, Funkhouser E et al. Patient-perceived barriers to antiretroviral adherence: associations with race. AIDS Care 2002;14:607-617.
33. Wellons MF, Sanders L, Edwards LJ, et al. HIV infection: Treatment outcomes in older and younger adults. J Am Geriatr Soc 2002;50:603-607.
34. Halkitis PN, Parsons JT, Wolitski RJ, Remien RH. Characteristics of HIV antiretroviral treatments, access and adherence in an ethnically diverse sample of men who have sex with men. AIDS Care 2003;15: 89-102.
35. Catz SL, McClure JB, Jones GN, Brantley PJ. Predictors of outpatient medical appointment adherence among persons with HIV. AIDS Care 1999;11:361-373.
36. Reynolds NR, Testa MA, Marc LG, et al. Factors influencing medication adherence beliefs and self-efficacy in persons naive to antiretroviral therapy: A multicenter, cross-sectional study. AIDS Behav 2004; 8:141-150.
37. Gebo KA, Keruly J, Moore RD. Association of social stress, illicit drug use, and health beliefs with nonadherence to antiretroviral therapy. J Gen Intern Med 2003;18:104-111.
38. Roberts KJ. Barriers to and facilitators of HIV-positive patients' adherence to antiretroviral treatment regimens. AIDS Patient Care STD 2000;14:155-168.
39. Durantes AJ, Bova CA, Fennie KP, et al. Home-based study of anti-HIV drug regimen adherence among HIV-infected women: Feasibility and preliminary results. AIDS Care 2003;15:103-115.
40. Murphy DA, Marelich WD, Hoffman D, Steers WN. Predictors of antiretroviral adherence. AIDS Care 2004;16:471-484.
41. Power R, Koopman C, Volk J, et al. Social support, substance use, and denial in relationship to antiretroviral treatment adherence among HIV-infected persons. AIDS Patient Care STD 2004;17:245-252.
42. Siegel K, Karus D, Dean L. Psychosocial characteristics of New York City HIV-infected women before and after the advent of HAART. Am J Public Health 2004;94:1127-1132.